AmerisourceBergen Pleads Guilty, Pays $260M For Repackaging Cancer Drugs

(September 28, 2017, 9:57 AM EDT) -- BROOKLYN, N.Y. — AmerisourceBergen Specialty Group on Sept. 27 pleaded guilty to illegally distributing adulterated cancer drugs and agreed to pay $260 million in criminal fines and criminal forfeiture (United States of America v. AmerisourceBergen Specialty Group, LLC, No. 17-cr-507, E.D. N.Y.)....